A DE VRIES - JoVE Visualize

Showing results (261-270 of 878) with videos related to

Pageof 88

Sort By:

Journal of Child Psychology and Psychiatry, and Allied Disciplines|August 22, 2014

Practitioner review: Effective ingredients of prevention programs for youth at risk of persistent juvenile delinquency--recommendations for clinical practiceSanne L A de Vries, Machteld Hoeve, Mark Assink, et al.

Experientia|October 15, 1977

Elevation of serum xanthine oxidase activity following halothane anesthesia in manS Giler, Y Eshel, J Pinkhas, et al.

Clinical Chemistry|November 1, 1978

Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standardsF A Muskiet, D C Fremouw-Ottevangers, G T Nagel, et al.

Clinical Genetics|September 1, 1988

A new family with the Townes-Brocks syndromeM A de Vries-Van der Weerd, P J Willems, H M Mandema, et al.

Hepato-Gastroenterology|August 5, 2000

Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: a prospective randomized trialA Königsrainer, B Riedmann, A De Vries, et al.

Nuclear Medicine Communications|May 1, 1991

New possibilities in erythrocyte survival studies with the application of a Well-type germanium semiconductor detectorR A De Vries, S J Oldenburg, T Thelosen, et al.

Journal of Clinical Medicine|June 24, 2022

Efficacy and Safety of Micropulse Transscleral CyclophotocoagulationVictor A de Vries, Jan Pals, Huub J Poelman, et al.

Clinical Chemistry|January 1, 1978

Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentographyF A Muskiet, D C Fremouw-Ottevangers, J van der Meulen, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 26, 2003

[Diagnosis of 5 patients with possible primary hemochromatosis]E M G Jacobs, R A de Vries, L D Elving, et al.

Transplantation|September 15, 1994

Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft toleranceA de Vries-van Der Zwan, A C Besseling, F Kievits, et al.

Pageof 88

Showing results (261-270 of 878) with videos related to

Sort By:

Pageof 88

Journal of Child Psychology and Psychiatry, and Allied Disciplines|August 22, 2014

Practitioner review: Effective ingredients of prevention programs for youth at risk of persistent juvenile delinquency--recommendations for clinical practiceSanne L A de Vries, Machteld Hoeve, Mark Assink, et al.

Experientia|October 15, 1977

Elevation of serum xanthine oxidase activity following halothane anesthesia in manS Giler, Y Eshel, J Pinkhas, et al.

Clinical Chemistry|November 1, 1978

Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standardsF A Muskiet, D C Fremouw-Ottevangers, G T Nagel, et al.

Clinical Genetics|September 1, 1988

A new family with the Townes-Brocks syndromeM A de Vries-Van der Weerd, P J Willems, H M Mandema, et al.

Hepato-Gastroenterology|August 5, 2000

Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: a prospective randomized trialA Königsrainer, B Riedmann, A De Vries, et al.

Nuclear Medicine Communications|May 1, 1991

New possibilities in erythrocyte survival studies with the application of a Well-type germanium semiconductor detectorR A De Vries, S J Oldenburg, T Thelosen, et al.

Journal of Clinical Medicine|June 24, 2022

Efficacy and Safety of Micropulse Transscleral CyclophotocoagulationVictor A de Vries, Jan Pals, Huub J Poelman, et al.

Clinical Chemistry|January 1, 1978

Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentographyF A Muskiet, D C Fremouw-Ottevangers, J van der Meulen, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 26, 2003

[Diagnosis of 5 patients with possible primary hemochromatosis]E M G Jacobs, R A de Vries, L D Elving, et al.

Transplantation|September 15, 1994

Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft toleranceA de Vries-van Der Zwan, A C Besseling, F Kievits, et al.

Pageof 88